Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma

被引:63
|
作者
Young, Jonathan R. [1 ]
Coy, Heidi [1 ]
Kim, Hyun J. [1 ]
Douek, Michael [1 ]
Lo, Pechin [1 ]
Pantuck, Allan J. [2 ]
Raman, Steven S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, 757 Westwood Plaza,Ste 1638, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
关键词
MRI; multiphasic; oncocytoma; renal cell carcinoma; PATHOLOGICAL FINDINGS; HISTOLOGIC SUBTYPES; HELICAL CT; TUMORS; CLASSIFICATION; NEOPLASMS; PARAMETERS; FEATURES; DISEASE; SYSTEM;
D O I
10.2214/AJR.16.17152
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the performance of relative enhancement on multiphasic MRI to differentiate clear cell renal cell carcinoma (RCC) from other RCC subtypes (papillary and chromophobe) and oncocytoma. MATERIALS AND METHODS. For this study, we derived a cohort of 34 clear cell RCCs, nine oncocytomas, 12 papillary RCCs, and 10 chromophobe RCCs with a preoperative multiphasic dynamic contrast-enhanced MRI study with up to four phases (i.e., unenhanced, corticomedullary, nephrographic, excretory) from 2005 to 2016. These groups were evaluated for multiphasic enhancement and were compared using Kruskal-Wallis and Mann-Whitney tests. ROC curves were constructed and logistic regression analyses were performed to evaluate the performance of multiphasic enhancement in differentiating clear cell RCCs from the other three groups. RESULTS. Clear cell RCCs exhibited significantly greater relative signal intensity compared with uninvolved renal cortex in the corticomedullary phase (mean, 2.9) than oncocytomas (-21.7, p = 0.001), papillary RCCs (-53.0, p < 0.001), and chromophobe RCCs (-21.0, p < 0.001). Relative signal intensity in the corticomedullary phase differentiated clear cell RCCs from oncocytomas with an AUC of 0.90 and with an accuracy of 84% (32/38), sensitivity of 90% (27/30), and specificity of 63% (5/8) after controlling for lesion size, patient age, and patient sex. Relative corticomedullary signal intensity differentiated clear cell RCCs from oncocytomas and other RCC subtypes with an AUC of 0.93 and with an accuracy of 90% (53/59), sensitivity of 90% (27/30), and specificity of 90% (26/29) after controlling for lesion size, patient age, and patient sex. CONCLUSION. Multiphasic MRI enhancement may assist in differentiating clear cell RCC from oncocytomas and other RCC subtypes, if validated in prospective studies.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 50 条
  • [41] CT prediction of the Fuhrman grade of clear cell renal cell carcinoma (RCC): towards the development of computer-assisted diagnostic method
    Huhdanpaa, Hannu
    Hwang, Darryl
    Cen, Steven
    Quinn, Brian
    Nayyar, Megha
    Zhang, Xuejun
    Chen, Frank
    Desai, Bhushan
    Liang, Gangning
    Gill, Inderbir
    Duddalwar, Vinay
    ABDOMINAL IMAGING, 2015, 40 (08): : 3168 - 3174
  • [42] Deep learning and radiomics: the utility of Google TensorFlow Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT
    Coy, Heidi
    Hsieh, Kevin
    Wu, Willie
    Nagarajan, Mahesh B.
    Young, Jonathan R.
    Douek, Michael L.
    Brown, Matthew S.
    Scalzo, Fabien
    Raman, Steven S.
    ABDOMINAL RADIOLOGY, 2019, 44 (06) : 2009 - 2020
  • [43] Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC): A systematic review of the literature
    Abdel-Rahman, Omar
    Fouad, Mona
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 238 - 250
  • [44] Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography
    Xue, Li-Yun
    Lu, Qing
    Huang, Bei-Jian
    Li, Zheng
    Li, Cui-Xian
    Wen, Jie-Xian
    Wang, Wen-Ping
    EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (10) : 1849 - 1856
  • [45] Clear cell papillary cystadenoma of the epididymis and mesosalpinx - Immunohistochemical differentiation from metastatic clear cell renal cell carcinoma
    Aydin, H
    Young, RH
    Ronnett, BM
    Epstein, JI
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (04) : 520 - 523
  • [46] Differentiation of Pathologic Subtypes of Papillary Renal Cell Carcinoma on CT
    Yamada, Takayuki
    Endo, Mareyuki
    Tsuboi, Masahiro
    Matsuhashi, Toshio
    Takase, Kei
    Higano, Shuichi
    Takahashi, Shoki
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (05) : 1559 - 1563
  • [47] A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRI
    Nikpanah, Moozhan
    Xu, Ziyue
    Jin, Dakai
    Farhadi, Faraz
    Saboury, Babak
    Ball, Mark W.
    Gautam, Rabindra
    Merino, Maria J.
    Wood, Bradford J.
    Turkbey, Baris
    Jones, Elizabeth C.
    Linehan, W. Marston
    Malayeri, Ashkan A.
    CLINICAL IMAGING, 2021, 77 : 291 - 298
  • [48] Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng, K. L.
    Del Vecchio, S. J.
    Samaratunga, H.
    Morais, C.
    Rajandram, R.
    Vesey, D. A.
    Wood, S. T.
    Gobe, G. C.
    PATHOLOGY, 2018, 50 (05) : 504 - 510
  • [49] Surgical treatment of atypical metastasis from renal cell carcinoma (RCC)
    Antonelli, Alessandro
    Arrighi, Nicola
    Corti, Serena
    Legramanti, Stefano
    Zanotelli, Tiziano
    Cozzoli, Alberto
    Cunico, Sergio Cosciani
    Simeone, Claudio
    BJU INTERNATIONAL, 2012, 110 (11B) : E559 - E563
  • [50] RCC-Ma loss predicts poor survival and metastatic risk in clear cell renal cell carcinoma
    Stenzel, P. J.
    Tagscherer, K. E.
    Justenhoven, C.
    Wild, P. J.
    Haferkamp, A.
    Macher-Goeppinger, S.
    Roth, W.
    Frees, S.
    Porubsky, S.
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 269